PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 1993 December; 92(6): 2713–2718.
PMCID: PMC288469

A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

Abstract

The genetic defect leading to cholesteryl ester storage disease (CESD) has been determined in a 12-yr-old patient. Lysosomal acid lipase (LAL) activity in cultured skin fibroblasts was reduced to approximately 9% of control fibroblasts. Plasma cholesterol (255 mg/dl) and LDL-cholesterol (215 mg/dl) were elevated whereas HDL-cholesterol was reduced (19 mg/dl). Triglycerides were moderately elevated (141 mg/dl). There were no clinical abnormalities with the exception of hepatosplenomegaly. Both parents have reduced LAL activity in white blood cells. PCR analysis of the LAL mRNA from the propositus revealed a single slightly smaller mRNA species in skin fibroblasts as well as in leukocytes. The mother of the patient and his older brother had two mRNA species: one of normal size and one of the same size as the propositus. The father has a LAL mRNA of normal size only. Sequence analysis of a PCR-amplified cDNA fragment showed a 72-bp in-frame deletion resulting in the loss of the codons for amino acids 254-277. Analysis of genomic DNA revealed that the 72 bp represent an exon, indicating that the deletion in the mRNA is caused by defective splicing. Sequence analysis of the patient's genomic DNA revealed a G-->A substitution in the last nucleotide of the 72-bp exon in one of his alleles. The mutant allele was shown to cosegregate with the truncated mRNA in the pedigree, providing further evidence that the G-->A substitution causes aberrant splicing and exon skipping. No normal-sized mRNA is detectable in the propositus even though he is not homozygous for the splice site mutation. This can be only accounted for by assuming that he is a compound heterozygote with a null allele inherited from his father. In summary, the data presented provide evidence that deletion of the codons for amino acids 254-277 in the LAL mRNA in combination with a null allele cause the clinical expression of CESD in our patient.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897–930. [PubMed]
  • Marshall WC, Ockenden BG, Fosbrooke AS, Cumings JN. Wolman's disease. A rare lipidosis with adrenal calcification. Arch Dis Child. 1969 Jun;44(235):331–341. [PMC free article] [PubMed]
  • Suzuki Y, Kawai S, Kobayashi A, Ohbe Y, Endo H. Partial deficiency of acid lipase with storage of triglycerides and cholesterol esters in liver. Genetic variant of Wolman's disease? Clin Chim Acta. 1976 Jun 1;69(2):219–224. [PubMed]
  • Ozoran Y, Ozoran A, Kerse I, Gürgey A, Ozsoylu S, Koçak N, Ciliv G. An ultrastructural study in a case of Wolman's disease (clinical, biochemical, light and electron microscopic study). Turk J Pediatr. 1978 Jul-Oct;20(3-4):100–107. [PubMed]
  • Schaub J, Janka GE, Christomanou H, Sandhoff K, Permanetter W, Hübner G, Meister P. Wolman's disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Eur J Pediatr. 1980 Oct;135(1):45–53. [PubMed]
  • Coates PM, Langer T, Cortner JA. Genetic variation of human mononuclear leukocyte lysosomal acid lipase activity. Relationship to atherosclerosis. Atherosclerosis. 1986 Oct;62(1):11–20. [PubMed]
  • Yatsu FM, Hagemenas FC, Manaugh LC, Galambos T. Cholesteryl ester hydrolase activity in human symptomatic atherosclerosis. Lipids. 1980 Dec;15(12):1019–1022. [PubMed]
  • Hagemenas FC, Manaugh LC, Illingworth DR, Sundberg EE, Yatsu FM. Cholesteryl ester hydrolase activity in mononuclear cells from patients with type II hypercholesterolemia. Atherosclerosis. 1984 Mar;50(3):335–344. [PubMed]
  • Tomita T, Shirasaki Y, Takiguchi Y, Ozaki Y, Hayashi E. Hemodynamic effects on aortic enzyme activities in spontaneously hypertensive rats. Atherosclerosis. 1980 Nov;37(3):409–422. [PubMed]
  • Wolinsky H, Capron L, Goldfischer S, Capron F, Coltoff-Schiller B, Kasak LE. Hydrolase activities in the rat aorta. II. Effects of hypertension alone and in combination with diabetes mellitus. Circ Res. 1978 Jun;42(6):831–839. [PubMed]
  • Nguyen VC, Weil D, Hors-Cayla MC, Gross MS, Heuertz S, Foubert C, Frezal J. Assignment of the genes for human lysosomal acid lipases A and B to chromosomes 10 and 16. Hum Genet. 1980;55(3):375–381. [PubMed]
  • Koch G, Lalley PA, McAvoy M, Shows TB. Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19. Somatic Cell Genet. 1981 May;7(3):345–358. [PubMed]
  • Anderson RA, Rao N, Byrum RS, Rothschild CB, Bowden DW, Hayworth R, Pettenati M. In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3. Genomics. 1993 Jan;15(1):245–247. [PubMed]
  • Anderson RA, Sando GN. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase. Similarities to gastric and lingual lipases. J Biol Chem. 1991 Nov 25;266(33):22479–22484. [PubMed]
  • Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. [PubMed]
  • Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. [PMC free article] [PubMed]
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. [PubMed]
  • Haley NJ, Fowler S, de Duve C. Lysosomal acid cholesteryl esterase activity in normal and lipid-laden aortic cells. J Lipid Res. 1980 Nov;21(8):961–969. [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet. 1992 Sep-Oct;90(1-2):41–54. [PubMed]
  • Grandchamp B, Picat C, de Rooij F, Beaumont C, Wilson P, Deybach JC, Nordmann Y. A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyria. Nucleic Acids Res. 1989 Aug 25;17(16):6637–6649. [PMC free article] [PubMed]
  • Weil D, D'Alessio M, Ramirez F, Steinmann B, Wirtz MK, Glanville RW, Hollister DW. Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J Biol Chem. 1989 Oct 5;264(28):16804–16809. [PubMed]
  • Akli S, Chelly J, Mezard C, Gandy S, Kahn A, Poenaru L. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. J Biol Chem. 1990 May 5;265(13):7324–7330. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation